3D bioprinted scaffolds for diabetic wound-healing applications

Author:

Glover KatieORCID,Mathew EssyroseORCID,Pitzanti GiuliaORCID,Magee Erin,Lamprou Dimitrios A.ORCID

Abstract

AbstractThe treatment strategy required for the effective healing of diabetic foot ulcer (DFU) is a complex process that is requiring several combined therapeutic approaches. As a result, there is a significant clinical and economic burden associated in treating DFU. Furthermore, these treatments are often unsuccessful, commonly resulting in lower-limb amputation. The use of drug-loaded scaffolds to treat DFU has previously been investigated using electrospinning and fused deposition modelling (FDM) 3D printing techniques; however, the rapidly evolving field of bioprinting is creating new opportunities for innovation within this research area. In this study, 3D-bioprinted scaffolds with different designs have been fabricated for the delivery of an antibiotic (levoflocixin) to DFU. The scaffolds were fully characterised by a variety of techniques (e.g. SEM, DSC/TGA, FTIR, and mechanical characterisation), demonstrating excellent mechanical properties and providing sustained drug release for 4 weeks. This proof of concept study demonstrates the innovative potential of bioprinting technologies in fabrication of antibiotic scaffolds for the treatment of DFU. Graphical abstract

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Reference49 articles.

1. Peter-Riesch B. The diabetic foot: the never-ending challenge. In: Diem P, editor. Stettler C, E C. Nov Diabetes. Basel: Karger; 2016. p. 108–34.

2. Jia L, Parker CN, Parker TJ, Kinnear EM, Derhy PH, Alvarado AM, et al. Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers. PLoS ONE. 2017;12:1–15.

3. Glover K, Ch Stratakos A, Varadi A, Lamprou DA. 3D Scaffolds in the treatment of diabetic foot ulcers: new trends vs conventional approaches. Int J Pharm [Internet]. Elsevier B.V. 2021;599:120423. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33647412.

4. International Diabetes Federation. About Diabetes [Internet]. 2020 [cited 2020 Nov 20]. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html#:~:text=Diabetesfacts%26figures,-Lastupdate%3A12&text= The IDF Diabetes Atlas Ninth,will rise to 700 million.

5. Fortune Business Insights. Diabetic foot ulcer treatment market size, share and COVID-19 impact analysis [Internet]. 2019 [cited 2020 Nov 20]. Available from: https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3